U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789028) titled 'A Study in Healthy People to Test How Zongertinib is Taken up in the Body When Given as Tablets Made by Two Different Manufacturers With or Without Food' on Aug. 24.

Brief Summary: The main objective of this trial is to establish the bioequivalence of Zongertinib tablets from two different manufacturers following oral administration.

Study Start Date: Sept. 09

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Zongertinib, Formulation A, reference product

Zongertinib, Formulation A, reference product

DRUG: Zongertinib Formulation B, test product

Zongertinib Formulation B, test product

Recruitment Status: NOT...